학술논문
Single priming and booster dose of ten-valent and 13-valent pneumococcal conjugate vaccines and Streptococcus pneumoniaecolonisation in children in South Africa: a single-centre, open-label, randomised trial
Document Type
Article
Author
Source
The Lancet Child & Adolescent Health; 20230101, Issue: Preprints
Subject
Language
ISSN
23524642; 23524650
Abstract
Pneumococcal conjugate vaccine (PCV) immunisation has reduced vaccine-serotype colonisation and invasive pneumococcal disease in South Africa, providing the opportunity to consider transitioning from a two-dose (2 + 1) to one-dose (1 + 1) primary series and a booster dose.